Sai Parenterals PE Ratio
Sai Parenterals Ltd
NSE: SAIPARENT
PE
Key Highlights
- The P/E Ratio of Sai Parenterals Ltd is 124.2 as of 06 Apr 26 The P/E Ratio of Sai Parenterals Ltd changed from 0 on March 2023 to 0 on March 2025 . This represents a CAGR of 0.0% over 3 years The Latest Trading Price of Sai Parenterals Ltd is ₹ 406 as of 06 Apr 15:30 The PE Ratio of Pharmaceuticals Industry has changed from 24.6 to 32.3 in 5 years. This represents a CAGR of 5.60% The PE Ratio of Automobile industry is 21.6. The PE Ratio of Finance industry is 19.0. The PE Ratio of IT - Software industry is 27.7. The PE Ratio of Pharmaceuticals industry is 32.3. The PE Ratio of Retail industry is 121.9. The PE Ratio of Textiles industry is 54.5 in 2025 .
Historical P/E Ratio of Sai Parenterals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Sai Parenterals Ltd
Company Fundamentals for Sai Parenterals Ltd
Sai Parenterals Ltd
NSE: SAIPARENT
Share Price
Market Price of Sai Parenterals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 06 Apr 2026 | 406 |
| 02 Apr 2026 | 406.4 |
BlinkX Score for Sai Parenterals Ltd
Asset Value vs Market Value of Sai Parenterals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
PE Ratio of Sai Parenterals Ltd Explained
₹1793
Market cap
₹10
Earnings
0.0X
PE Ratio
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Sai Parenterals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Sai Parenterals Ltd
Historical Revenue, EBITDA and Net Profit of Sai Parenterals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Sai Parenterals Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Sai Parenterals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Sai Parenterals Ltd
About Sai Parenterals Ltd
- Sai Parenteral's Limited was originally incorporated as Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad.
- Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to Sai Parenteral's Limited' w.e.f January 17, 2022. Sai Parenteral's is a diversified pharmaceutical formulations company engaged in the business of Branded Generic Formulations and Contract Development and Manufacturing Organization (CDMO) products and services for the domestic and international markets.
- Company has developed a comprehensive and diversified portfolio of complex pharmaceutical products, covering both high-value and high-volume categories addressing critical therapeutic needs across the multiple disease areas.
Sai Parenterals Ltd News Hub
Sai Parenteral's IPO subscribed 41%
The initial public offer (IPO) of Sai Parenteral's received bids for 30,82,788 shares as against 75,
Read more
25 Mar 26
Sai Parenteral's IPO subscribed 1.01 times
The initial public offer (IPO) of Sai Parenteral's received bids for 78,80,972 shares as against 75,
Read more
27 Mar 26
Sai Parenteral's IPO ends with 1.05 times subscription
The initial public offer (IPO) of Sai Parenteral's received bids for 78,80,972 shares as against 75,
Read more
30 Mar 26
Sai Parenterals IPO lists today in B group
The equity shares of Sai Parenterals (Scrip Code: 544742) are listed effective 02 April 2026 and adm
Read more
02 Apr 26
